Form 4: Exelixis EVP, Commercial, Patrick J. Haley, Executes Stock Sales Under 10b5-1 Plan

Exelixis's EVP, Commercial, Patrick J. Haley, sold a total of 41,588 shares of common stock in multiple transactions, while also having shares withheld for tax obligations.

Summary

• Patrick J. Haley, EVP, Commercial at Exelixis, Inc., reported transactions involving the company's common stock.
• On November 15, 2024, 14,672 shares were withheld to cover tax obligations related to vesting performance-based restricted stock units.
• On November 18, 2024, Haley sold 22,207 shares at a weighted average price of $34.31 and 19,381 shares at a weighted average price of $34.41.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 19, 2024.
• Following these transactions, Haley directly owns 308,046 shares and indirectly owns 23,539 shares through his spouse and 10,648 shares through his 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive, which is neither positive nor negative in itself. The use of a 10b5-1 plan suggests the transactions were planned and not based on any new information.

Risks

• The sales by an executive could be perceived negatively by the market, although they were conducted under a pre-arranged trading plan.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid accusations of insider trading. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies like Exelixis to manage their stock sales and avoid insider trading allegations.
• Similar filings are regularly made by executives at comparable biotech companies such as Gilead Sciences, Amgen, and Biogen, reflecting standard practices for stock transactions.
• The reported sales are within the typical range for executive transactions, and the price ranges are consistent with market fluctuations for the stock.

Stakeholder Impact

• The stock sales by an executive could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Exelixis, insider trading, stock sale, Form 4, Rule 10b5-1, executive compensation, equity securities